Yolanda Barbachano Selected Research

Yolanda Barbachano Research Topics

4	Neoplasms (Cancer) 01/2018 - 06/2009
3	Colorectal Neoplasms (Colorectal Cancer) 03/2013 - 04/2009
3	Rectal Neoplasms (Rectal Cancer) 05/2012 - 04/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 03/2013 - 08/2012
2	Disease Progression 08/2012 - 08/2011
2	Prostatic Neoplasms (Prostate Cancer) 12/2009 - 06/2007
1	Infections 01/2019
1	Acute Promyelocytic Leukemia 01/2019
1	Hemorrhage 01/2019
1	Adenocarcinoma 05/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 02/2012
1	Hypopharyngeal Neoplasms 02/2012
1	Thyroid Neoplasms (Thyroid Cancer) 08/2011
1	Testicular Neoplasms (Testicular Cancer) 05/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2010
1	Raynaud Disease (Raynaud's Disease) 05/2010
1	Anaplastic Thyroid Carcinoma 06/2009
1	Lung Neoplasms (Lung Cancer) 05/2009
1	Squamous Cell Carcinoma of Head and Neck 05/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2008
1	Spinal Cord Compression 12/2007
1	Neurologic Manifestations (Neurological Manifestations) 12/2007
1	Back Pain (Backache) 12/2007

3	Capecitabine (Xeloda)FDA Link 05/2013 - 03/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2013 - 03/2010
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2019
1	Liposomes (Liposome)IBA 01/2020
1	Gemtuzumab (Mylotarg)FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	Panitumumab (Vectibix)FDA Link 05/2013
1	Epirubicin (Ellence)FDA LinkGeneric 05/2013
1	Bevacizumab (Avastin)FDA Link 03/2013
1	Cetuximab (Erbitux)FDA Link 05/2012
1	Sorafenib (BAY 43-9006)FDA Link 08/2011
1	Carboplatin (JM8)FDA LinkGeneric 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 05/2010
1	Biological ProductsIBA 12/2009
1	Biomarkers (Surrogate Marker)IBA 12/2009
1	Rad51 RecombinaseIBA 12/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2009
1	ErbB Receptors (EGF Receptor)IBA 05/2009
1	Fluorouracil (Carac)FDA LinkGeneric 04/2009
1	Leucovorin (Folinic Acid)FDA Link 04/2009
1	Gefitinib (Iressa)FDA Link 02/2008
1	Docetaxel (Taxotere)FDA Link 02/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2008
1	Follicle Stimulating Hormone (Follitropin)FDA Link 06/2007
1	Testosterone (Sustanon)FDA Link 06/2007
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2007
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 06/2007

5	Drug Therapy (Chemotherapy) 05/2013 - 05/2010
4	Therapeutics 01/2020 - 03/2010
4	Radiotherapy 05/2012 - 06/2007
2	Neoadjuvant Therapy 08/2012 - 05/2012
2	Chemoradiotherapy 05/2012 - 03/2010
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2012
1	Induction Chemotherapy 02/2012
1	Combination Drug Therapy (Combination Chemotherapy) 03/2010
1	Adjuvant Chemotherapy 04/2009
1	Aftercare (After-Treatment) 06/2007